End-stage kidney disease (ESKD) is a serious and life-threatening condition that affects millions of people worldwide. In Northern Ghana, the prevalence of ESKD is on the rise, leading to an increased demand for haemodialysis treatment. Haemodialysis is a common treatment option for patients with ESKD, as it helps to remove waste products and excess fluids from the blood when the kidneys are no longer able to do so.
A recent qualitative study published in BMC Nephrology aimed to explore the experiences of ESKD patients on haemodialysis in Northern Ghana. The study, conducted by researchers from the University for Development Studies in Tamale, Ghana, involved interviews with 15 patients receiving haemodialysis treatment at a regional hospital.
The findings of the study shed light on the challenges faced by ESKD patients in Northern Ghana. One of the key themes that emerged from the interviews was the financial burden of haemodialysis treatment. Many patients reported struggling to afford the cost of treatment, which often required them to sell their assets or rely on financial support from family members. This financial strain not only affected their ability to access treatment but also impacted their overall quality of life.
In addition to financial challenges, patients also reported experiencing physical and emotional distress as a result of their condition. The grueling nature of haemodialysis treatment, which often requires patients to spend several hours at the hospital multiple times a week, took a toll on their physical well-being. Many patients also expressed feelings of anxiety, depression, and isolation, as they struggled to cope with the demands of their illness.
Despite these challenges, the study also highlighted the resilience and determination of ESKD patients in Northern Ghana. Many patients spoke about the importance of faith, family support, and a positive attitude in helping them navigate their illness. Some patients also emphasized the need for improved access to healthcare services and financial assistance for those in need.
Overall, the findings of this study provide valuable insights into the experiences of ESKD patients on haemodialysis in Northern Ghana. By understanding the challenges faced by these patients, healthcare providers and policymakers can work towards improving access to care, addressing financial barriers, and providing holistic support to enhance the quality of life for individuals living with ESKD in the region.